Trump administration ending multiple HIV vaccine studies, scientists and officials say
CBSN
The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus, multiple scientists and federal health officials say.
Notifications that the funding would not be extended were relayed Friday to researchers, who were told by National Institutes of Health officials that the Department of Health and Human Services had elected "to go with currently available approaches to eliminate HIV" instead.
The cuts will shutter two major HIV vaccine research efforts that were first funded by the NIH in 2012 at the Duke Human Vaccine Institute and the Scripps Research Institute, multiple scientists said. A spokesperson for Moderna said the vaccine manufacturer's clinical trials through the NIH's HIV Vaccine Trials Network have also been put on pause.

As the Trump administration continues to prepare military options for strikes in Iran, U.S. allies in the Mideast, including Turkey, Oman and Qatar, are attempting to head off that possibility by brokering diplomatic talks, multiple regional officials told CBS News. Camilla Schick and Eleanor Watson contributed to this report.

Another winter storm may be headed toward the East Coast of the United States this weekend, on the heels of a powerful and deadly system that blanketed huge swaths of the country in snow and ice. The effects of that original storm have lingered for many areas in its path, and will likely remain as repeated bouts of Arctic air plunge downward from Canada and drive temperatures below freezing. Nikki Nolan contributed to this report. In:











